Holen Sie sich die Stockscreener-App
37.48
2.32%
0.85
Vorhandelsmarkt:
37.49
0.01
+0.03%
Schlusskurs vom Vortag:
$36.63
Offen:
$36.5
24-Stunden-Volumen:
2.33M
Relative Volume:
0.62
Marktkapitalisierung:
$16.20B
Einnahmen:
$2.31B
Nettoeinkommen (Verlust:
$1.66B
KGV:
16.30
EPS:
2.3
Netto-Cashflow:
$827.02M
1W Leistung:
+4.11%
1M Leistung:
+3.42%
6M Leistung:
+16.43%
1J Leistung:
+35.06%
1-Tages-Spanne:
$36.50
$37.52
1-Wochen-Bereich:
$35.79
$37.52
52-Wochen-Spanne:
$24.05
$38.00
Royalty Pharma Plc Stock (RPRX) Company Profile
Firmenname
Royalty Pharma Plc
Sektor
Branche
Telefon
(212) 883-0200
Adresse
110 EAST 59TH STREET, NEW YORK, NY
Vergleichen Sie RPRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
37.48 | 15.83B | 2.31B | 1.66B | 827.02M | 2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.27 | 107.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
474.00 | 64.39B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
579.34 | 61.13B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
834.75 | 52.30B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.31 | 35.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-30 | Eingeleitet | Goldman | Buy |
| 2025-05-16 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-06-03 | Herabstufung | UBS | Buy → Neutral |
| 2022-06-14 | Fortgesetzt | UBS | Buy |
| 2022-05-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2022-04-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-10-29 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-07-30 | Eingeleitet | Tigress Financial | Buy |
| 2020-11-09 | Hochstufung | UBS | Neutral → Buy |
| 2020-07-14 | Eingeleitet | Evercore ISI | In-line |
| 2020-07-13 | Eingeleitet | BofA Securities | Buy |
| 2020-07-13 | Eingeleitet | Citigroup | Neutral |
| 2020-07-13 | Eingeleitet | Cowen | Outperform |
| 2020-07-13 | Eingeleitet | Goldman | Neutral |
| 2020-07-13 | Eingeleitet | JP Morgan | Neutral |
| 2020-07-13 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-07-13 | Eingeleitet | SunTrust | Buy |
| 2020-07-13 | Eingeleitet | UBS | Neutral |
Alle ansehen
Royalty Pharma Plc Aktie (RPRX) Neueste Nachrichten
Why Royalty Pharma plc (RPD) stock could outperform next year2025 Bull vs Bear & Real-Time Volume Analysis - newser.com
Is Royalty Pharma plc reversing from oversold territoryJuly 2025 Technicals & Community Trade Idea Sharing Platform - newser.com
Does Royalty Pharma plc qualify in momentum factor screeningWeekly Profit Report & Free Low Drawdown Momentum Trade Ideas - newser.com
What the charts say about Royalty Pharma plc todayJuly 2025 PostEarnings & Step-by-Step Swing Trade Plans - newser.com
What analysts say about Royalty Pharma plc stockEmerging Market Stocks & Subscribe for Free Weekly Winners - earlytimes.in
Royalty Pharma PLC $RPRX Shares Bought by TD Asset Management Inc - MarketBeat
Royalty Pharma PLC (NASDAQ:RPRX) Short Interest Update - MarketBeat
Allianz Asset Management GmbH Increases Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
Is Royalty Pharma plc (RPD) stock a buy during volatile markets2025 Technical Overview & Free Fast Entry Momentum Trade Alerts - newser.com
Detecting support and resistance levels for Royalty Pharma plcEarnings Risk Summary & Precise Entry and Exit Recommendations - newser.com
Is Royalty Pharma plc (RPD) stock undervalued historicallyWeekly Trading Summary & Verified Technical Trade Signals - nchmf.gov.vn
Is this a good reentry point in Royalty Pharma plcWeekly Stock Recap & Stepwise Trade Signal Guides - newser.com
Using Python tools to backtest Royalty Pharma plc strategiesWeekly Profit Analysis & Stock Portfolio Risk Management - newser.com
What candlestick patterns are forming on Royalty Pharma plcWeekly Gains Report & Smart Money Movement Tracker - newser.com
What indicators show strength in Royalty Pharma plcQuarterly Earnings Report & Safe Capital Growth Tips - newser.com
Price-Driven Insight from (RPRX) for Rule-Based Strategy - news.stocktradersdaily.com
Unlocking Q1 Potential of Royalty Pharma (RPRX): Exploring Wall Street Estimates for Key Metrics - sharewise.com
Nordea Investment Management AB Boosts Position in Royalty Pharma PLC $RPRX - MarketBeat
Why retail investors pile into Royalty Pharma plc stockMarket Weekly Review & Daily Risk Controlled Trade Plans - newser.com
Royalty Pharma PLC (NASDAQ:RPRX) to Issue Quarterly Dividend of $0.22 - MarketBeat
Is Royalty Pharma plc (RPD) stock bottoming after sell offEarnings Risk Summary & Stepwise Swing Trade Plans - nchmf.gov.vn
How strong is Royalty Pharma plc stock revenue growth2025 Key Lessons & Proven Capital Preservation Tips - nchmf.gov.vn
Market Moves: How strong is Royalty Pharma plc stock revenue growthTake Profit & Precise Buy Zone Identification - nchmf.gov.vn
Will Royalty Pharma plc stock benefit from upcoming earnings reports2025 EndofYear Setup & Consistent Return Strategy Ideas - nchmf.gov.vn
Trading Recap: Is Royalty Pharma plc (RPD) stock positioned for secular growth2025 Technical Overview & Fast Exit and Entry Strategy Plans - nchmf.gov.vn
Why Royalty Pharma plc stock is a must watch in 2025July 2025 Rallies & Stock Market Timing Techniques - nchmf.gov.vn
Royalty Pharma Keeps Quarterly Dividend at $0.22 a Share, Payable Dec. 10 to Holders of Record on Nov. 14 - MarketScreener
Royalty Pharma plc Approves Dividend on Class A Ordinary Share for Fourth Quarter of 2025 , Payable on December 10, 2025 - MarketScreener
Royalty Pharma plc Announces Fourth Quarter 2025 Dividend of $0.22 per Class A Ordinary Share - Quiver Quantitative
Royalty Pharma Declares Fourth Quarter 2025 Dividend - Bluefield Daily Telegraph
$0.22 Q4 2025 Dividend: Royalty Pharma Declares Payment Dec 10, Record Date Nov 14, 2025 - Stock Titan
Aberdeen Group plc Grows Position in Royalty Pharma PLC $RPRX - MarketBeat
S Bank Fund Management Ltd Buys Shares of 43,508 Royalty Pharma PLC $RPRX - MarketBeat
Is Royalty Pharma plc RPD a good long term investmentEarnings Per Share Trends & Big Returns, Small Investment – Learn How - earlytimes.in
What’s the recovery path for long term holders of Royalty Pharma plcMarket Risk Analysis & Safe Capital Growth Trade Ideas - newser.com
Morningstar Investment Management LLC Acquires Shares of 8,307 Royalty Pharma PLC $RPRX - MarketBeat
Callan Family Office LLC Buys Shares of 16,418 Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (RPRX) Valuation: Is There More Upside After This Year’s 40% Rally? - Yahoo Finance
Finanzdaten der Royalty Pharma Plc-Aktie (RPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.31%
1.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):